Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-May-23 9:00 AM View:  | Atyr Pharma Inc (LIFE) | 10-May-23 | Private Purchase | 200,000 | $2.25 | $450,000.00 | 25% 801.06K to 1.0M | |
| 28-Apr-23 4:54 PM View: | Atyr Pharma Inc (LIFE) | 26-Apr-23 | Option Exercise | 6,000 | -- | -- | < 1% 795.06K to 801.06K | |
| 22-Sep-21 10:00 PM View: | Atyr Pharma Inc (LIFE) | 20-Sep-21 | Gift | 250,000 | -- | -- | 46% 545.06K to 795.06K | |
| 22-Sep-21 10:00 PM View: | Atyr Pharma Inc (LIFE) | 20-Sep-21 | Gift | 250,000 | -- | -- | (24%) 1.05M to 795.06K | |
| 22-Sep-21 10:00 PM View: | Atyr Pharma Inc (LIFE) | 20-Sep-21 | Private Purchase | 250,000 | $8.00 | $2,000,000.00 | 31% 795.06K to 1.05M | |
| 20-May-21 8:55 AM View: | Atyr Pharma Inc (LIFE) | 18-May-21 | Market Purchase | 50,000 | $3.98 | $199,000.00 | 10% 495.06K to 545.06K | |
| 22-May-20 8:13 PM View: | Atyr Pharma Inc (LIFE) | 20-May-20 | Market Sale | 8,447 | $3.64 | $30,738.60 | (2%) 503.5K to 495.06K | (17%) |
| 11-Feb-20 11:58 AM View: | Atyr Pharma Inc (LIFE) | 10-Feb-20 | Market Purchase | 254,000 | $4.25 | $1,079,500.00 | 102% 249.5K to 503.5K | (< 1%) |
| 16-Apr-19 4:31 PM View: | Atyr Pharma Inc (LIFE) | 12-Apr-19 | Grant | 1,848,430 | $0.54 | $1,000,000.00 | 112% 1.64M to 3.49M | (43%) |
| 28-Nov-18 7:12 PM View: | Atyr Pharma Inc (LIFE) | 26-Nov-18 | Market Purchase | 147,225 | $0.54 | $79,796.00 | 10% 1.5M to 1.64M | (45%) |
| 05-Sep-18 4:04 PM View: | Atyr Pharma Inc (LIFE) | 04-Sep-18 | Market Purchase | 20,749 | $0.76 | $15,709.10 | 1% 1.48M to 1.5M | (61%) |
| 05-Sep-18 4:04 PM View: | Atyr Pharma Inc (LIFE) | 31-Aug-18 | Market Purchase | 22,000 | $0.72 | $15,752.00 | 2% 1.45M to 1.48M | (59%) |
| 31-Aug-18 4:11 PM View: | Atyr Pharma Inc (LIFE) | 30-Aug-18 | Market Purchase | 89,275 | $0.76 | $67,483.00 | 7% 1.37M to 1.45M | (61%) |
| 31-Aug-18 4:11 PM View: | Atyr Pharma Inc (LIFE) | 29-Aug-18 | Market Purchase | 75,136 | $0.72 | $54,090.40 | 6% 1.29M to 1.37M | (59%) |
| 21-May-18 6:50 PM View: | Atyr Pharma Inc (LIFE) | 18-May-18 | Market Purchase | 150,000 | $1.00 | $149,445.00 | 13% 1.14M to 1.29M | (70%) |
| 14-Mar-18 7:39 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Mar-18 | Option Exercise | 27,823 | $49.24 | $1,369,930.00 | 9% 307.0K to 334.82K | |
| 14-Mar-18 7:39 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Mar-18 | Market Option Sale (Planned) | 27,823 | $150.00 | $4,173,450.00 | (8%) 334.82K to 307.0K | 44% |
| 05-Sep-17 8:22 PM View: | Atyr Pharma Inc (LIFE) | 31-Aug-17 | Private Purchase | 94,336 | $2.65 | $249,990.00 | 9% 1.05M to 1.14M | |
| 21-Apr-17 5:34 PM View: | Forte Biosciences, Inc. (FBRX) | 19-Apr-17 | Conversion | 23,464 | -- | -- | 100% 0 to 23.46K | |
| 21-Apr-17 5:34 PM View: | Forte Biosciences, Inc. (FBRX) | 19-Apr-17 | Conversion | 11,363 | -- | -- | 48% 23.46K to 34.83K | |
| 21-Apr-17 5:34 PM View: | Forte Biosciences, Inc. (FBRX) | 19-Apr-17 | Purchase | 10,000 | $10.00 | $100,000.00 | 29% 34.83K to 44.83K | |
| 22-Dec-16 11:53 AM View: | Atyr Pharma Inc (LIFE) | 21-Dec-16 | Market Purchase | 10,000 | $2.28 | $22,818.00 | < 1% 1.04M to 1.05M | (87%) |
| 22-Dec-16 11:53 AM View: | Atyr Pharma Inc (LIFE) | 20-Dec-16 | Market Purchase | 15,000 | $2.27 | $34,110.00 | 1% 1.02M to 1.04M | (87%) |
| 19-Dec-16 7:41 PM View: | Atyr Pharma Inc (LIFE) | 16-Dec-16 | Market Purchase | 10,000 | $2.40 | $23,973.00 | < 1% 1.01M to 1.02M | (88%) |
| 19-Dec-16 7:41 PM View: | Atyr Pharma Inc (LIFE) | 15-Dec-16 | Market Purchase | 40,000 | $2.50 | $99,912.00 | 4% 970.84K to 1.01M | (88%) |
| 19-Dec-16 7:41 PM View: | Atyr Pharma Inc (LIFE) | 23-Sep-16 | Gift | 12,572 | -- | -- | 1% 970.84K to 983.41K | |
| 19-Dec-16 7:41 PM View: | Atyr Pharma Inc (LIFE) | 23-Sep-16 | Gift | 12,572 | -- | -- | (1%) 983.41K to 970.84K | |
| 15-Apr-16 5:46 PM View: | Atyr Pharma Inc (LIFE) | 14-Apr-16 | Market Purchase | 33,619 | $4.22 | $141,859.00 | 4% 904.62K to 938.24K | (93%) |
| 15-Apr-16 5:46 PM View: | Atyr Pharma Inc (LIFE) | 14-Apr-16 | Market Purchase | 32,600 | $4.14 | $135,075.00 | 3% 938.24K to 970.84K | (93%) |
| 14-Apr-16 7:20 PM View: | Atyr Pharma Inc (LIFE) | 13-Apr-16 | Market Purchase | 9,835 | $3.85 | $37,864.80 | 1% 894.78K to 904.62K | (92%) |
| 13-Apr-16 6:34 PM View: | Atyr Pharma Inc (LIFE) | 12-Apr-16 | Market Purchase | 2,581 | $3.75 | $9,681.85 | < 1% 885.65K to 888.24K | (92%) |
| 13-Apr-16 6:34 PM View: | Atyr Pharma Inc (LIFE) | 12-Apr-16 | Market Purchase | 6,546 | $3.70 | $24,219.50 | < 1% 888.24K to 894.78K | (92%) |
| 12-Apr-16 3:57 PM View: | Atyr Pharma Inc (LIFE) | 11-Apr-16 | Market Purchase | 32,659 | $3.57 | $116,535.00 | 4% 853.0K to 885.65K | (92%) |
| 11-Apr-16 12:39 PM View: | Atyr Pharma Inc (LIFE) | 08-Apr-16 | Market Purchase | 85,000 | $3.22 | $273,649.00 | 11% 768.0K to 853.0K | (91%) |
| 08-Apr-16 12:19 PM View: | Atyr Pharma Inc (LIFE) | 07-Apr-16 | Market Purchase | 40,000 | $3.19 | $127,584.00 | 5% 728.0K to 768.0K | (91%) |
| 07-Apr-16 3:40 PM View: | Atyr Pharma Inc (LIFE) | 06-Apr-16 | Market Purchase | 25,000 | $3.20 | $80,000.00 | 4% 703.0K to 728.0K | (91%) |
| 06-Apr-16 7:19 PM View: | Atyr Pharma Inc (LIFE) | 05-Apr-16 | Market Purchase | 25,000 | $3.52 | $88,117.50 | 4% 678.0K to 703.0K | (92%) |
| 22-Dec-15 4:36 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-Nov-15 | Gift | 4,000 | -- | -- | (1%) 311.0K to 307.0K | |
| 29-Jan-16 6:08 PM View: | Atyr Pharma Inc (LIFE) | 16-Sep-15 | Gift | 11,925 | -- | -- | (2%) 689.92K to 678.0K | |
| 14-May-15 9:20 PM View: | Atyr Pharma Inc (LIFE) | 12-May-15 | Conversion | 547,353 | -- | -- | 384% 142.57K to 689.92K | |
| 23-Apr-15 4:43 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 21-Apr-15 | Option Exercise | 10,000 | $28.68 | $286,850.00 | 3% 311.0K to 321.0K | |
| 23-Apr-15 4:43 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 21-Apr-15 | Market Option Sale (Planned) | 10,000 | $130.02 | $1,300,200.00 | (3%) 321.0K to 311.0K | 36% |
| 19-Mar-15 6:49 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-Mar-15 | Option Exercise | 9,053 | $27.28 | $246,966.00 | 3% 311.0K to 320.05K | |
| 19-Mar-15 6:49 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-Mar-15 | Market Option Sale (Planned) | 9,053 | $120.00 | $1,086,360.00 | (3%) 320.05K to 311.0K | 30% |
| 19-Mar-15 6:49 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 17-Mar-15 | Option Exercise | 947 | $27.28 | $25,834.20 | < 1% 311.0K to 311.94K | |
| 19-Mar-15 6:49 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 17-Mar-15 | Market Option Sale (Planned) | 947 | $120.00 | $113,640.00 | (< 1%) 311.94K to 311.0K | 30% |
| 10-Dec-14 4:39 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 08-Dec-14 | Option Exercise | 15,000 | $22.09 | $331,350.00 | 5% 311.0K to 326.0K | |
| 10-Dec-14 4:39 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 08-Dec-14 | Market Option Sale (Planned) | 15,000 | $105.00 | $1,575,000.00 | (5%) 326.0K to 311.0K | 20% |
| 30-Oct-14 5:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 28-Oct-14 | Option Exercise | 15,000 | $15.91 | $238,650.00 | 5% 311.0K to 326.0K | |
| 30-Oct-14 5:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 28-Oct-14 | Market Option Sale (Planned) | 15,000 | $95.00 | $1,425,000.00 | (5%) 326.0K to 311.0K | 12% |